Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07129876 · ClinicalTrials.gov registry record · NA
Motion Fidelity Effects With Mixed-Reality
A NA study, sponsored by National Aeronautics and Space Administration (NASA).
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT07129876: Completed NA study, sponsored by National Aeronautics and Space Administration (NASA).
NCT07129876 is a NA study that has completed, run by National Aeronautics and Space Administration (NASA). The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07129876, a NA study, has completed, sponsored by National Aeronautics and Space Administration (NASA).
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this research is to investigate how different levels of simulator motion fidelity affect pilot performance in two different flight tasks while using a head mounted display (or mixed-reality headset) for out-the-window (OTW) visuals. Three levels of motion fidelity will be studied: 1) no motion, 2) small hexapod motion, and 3) one-to-one vehicle motion.
Primary Outcome
Time needed to complete (a portion of) the flight task measured against desired and adequate performance criteria: Heliport Approach Task - Battery time remaining (desired \>=20:00 min, adequate \>=19:40 min) Lateral Reposition and Hold Task \- Reposition completion time (desired \<=25 s, adequate \<=35 s)
Interventions
- OTHER Simulator Motion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2025-05-19 |
| Est. Completion | 2025-05-30 |
| Phase | NA |
What the finished NCT07129876 record still lists
NCT07129876 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Simulator Motion is the first listed.
NCT07129876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07129876 about?
NCT07129876 is a clinical study titled "Motion Fidelity Effects With Mixed-Reality". The purpose of this research is to investigate how different levels of simulator motion fidelity affect pilot performance in two different flight tasks while using a head mounted display (or mixed-reality headset) for out-the-window (OTW) visuals. Three levels of motion fidelity will be studied: 1) ...
What is the current status of trial NCT07129876?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2025-05-19. Estimated completion is 2025-05-30.
What interventions are being tested in trial NCT07129876?
The interventions under investigation include: Simulator Motion (OTHER).
Who is sponsoring clinical trial NCT07129876?
This trial is sponsored by National Aeronautics and Space Administration (NASA), which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07129876's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI